| abstract |
The present invention provides a nasal vaccine capable of intranasally inducing an effective immunity reaction. Specifically, the invention provides a nasal vaccine containing a compound having an NKT cell-activating action, particularly a compound represented by the formula (I): n n n n n n n n n n wherein each symbol is as defined in the specification, or a compound represented by the formula (II): n n n n n n n n n n wherein each symbol is as defined in the specification, and an immunogen in an amount effective for stimulating an immune response. |